Research conducted by Bill Shew, Alison Little, and Peter Gilmore from KPMG summarized the state of most life sciences organisations as follows: “Life sciences companies face increasingly high demands from payers to prove the value of their products in terms of improved patient outcomes and lower costs. This requires not […]